Clearstead Advisors LLC Has $3.53 Million Holdings in Markel Group Inc. $MKL

Clearstead Advisors LLC trimmed its stake in shares of Markel Group Inc. (NYSE:MKL) by 37.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,849 shares of the insurance provider’s stock after selling 1,112 shares during the period. Clearstead Advisors LLC’s holdings in Markel Group were worth $3,534,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Clearstead Trust LLC lifted its holdings in Markel Group by 180.0% during the 2nd quarter. Clearstead Trust LLC now owns 14 shares of the insurance provider’s stock worth $28,000 after buying an additional 9 shares in the last quarter. Chilton Capital Management LLC acquired a new position in shares of Markel Group during the second quarter valued at $32,000. GoalVest Advisory LLC bought a new position in Markel Group in the third quarter valued at about $38,000. Hemington Wealth Management increased its position in Markel Group by 35.3% in the third quarter. Hemington Wealth Management now owns 23 shares of the insurance provider’s stock worth $43,000 after purchasing an additional 6 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Markel Group by 316.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 25 shares of the insurance provider’s stock worth $48,000 after purchasing an additional 19 shares during the last quarter. 77.12% of the stock is owned by institutional investors.

Markel Group Stock Performance

MKL opened at $2,064.16 on Tuesday. The firm has a fifty day moving average price of $2,100.32 and a 200 day moving average price of $2,018.15. Markel Group Inc. has a 1 year low of $1,621.89 and a 1 year high of $2,207.59. The stock has a market cap of $26.03 billion, a P/E ratio of 12.16 and a beta of 0.79. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.60 and a quick ratio of 0.60.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MKL. Truist Financial boosted their price target on shares of Markel Group from $2,000.00 to $2,100.00 and gave the stock a “hold” rating in a research note on Friday, February 6th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Markel Group in a research report on Monday, December 29th. Finally, Zacks Research lowered Markel Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 19th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $2,100.00.

Insider Activity at Markel Group

In related news, Director Steven A. Markel sold 1,330 shares of Markel Group stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $2,119.12, for a total value of $2,818,429.60. Following the completion of the transaction, the director owned 60,368 shares in the company, valued at $127,927,036.16. The trade was a 2.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders sold 1,500 shares of company stock worth $3,175,430. 1.66% of the stock is owned by company insiders.

Markel Group Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.